The Union government had made an advance payment of Rs 1,500 crore in June 2021 for reserving 30 crore doses. Biological E, a Hyderabad-based vaccine manufacturer, on Monday received emergency use authorisation (EUA) from India’s drug regulator for their Covid-19 vaccine for the 12 to 18-year age group. The Drugs Controller General of India (DCGI) … Read more
According to the health ministry, the company has conducted phase 1/2 and 2/3 clinical trials of its COVID-19 vaccine in the country. The Drugs Controller General of India has granted restricted emergency use authorisation (EUA) to Biological E’s COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official sources … Read more
If and when the recommendation for a booster is made, beneficiaries vaccinated with Covishield, Sputnik V, and are likely to have multiple options. (File) A Covid-19 booster dose, when administered, should be of a vaccine based on a different platform than the first two doses, according to preliminary consensus reached by India’s top technical advisory … Read more
Everything about Biological E Corbevax vaccine (Representative Image, IE) Corbevax has secured permission for the third phase clinical trials of the vaccine and the government is expecting the trials to be over by July. The government has also placed an order of 300 million doses of the vaccine produced by Hyderabad -based Biological E. Here’s … Read more